Platelet Membrane and miR-181a-5p Doubly Optimized Nanovesicles Enhance Cardiac Repair Post-Myocardial Infarction through Macrophage Polarization
Macrophages play a crucial role in cardiac remodeling and prognosis after myocardial infarction (MI). Our previous studies have built a scalable method for preparing scaled stem cell nanovesicles (NVs) and demonstrated their remarkable reparative effects on ischemic heart disease. To further enhance the targeted reparative capabilities of the NVs toward injured myocardium, we employed a dual modification strategy involving platelet membrane coating and miR-181a-5p loading, creating a nanovesicle termed P-181-NV. This study aimed to investigate the efficacy of P-181-NV in targeted reparative interventions for damaged myocardium and to reveal the underlying mechanisms involved. After successful construction and characteristic analysis of P-181-NV, the <i>in vivo</i> tracking techniques demonstrated a significant enhancement in the targeting capacity of P-181-NV toward the injured myocardium. Moreover, P-181-NV showed marked improvements in cardiac function and remodeling as observed through ultrasound echocardiography and Masson's trichrome staining. Furthermore, P-181-NV significantly augmented myocardial cell viability, angiogenic potential, and the polarization ratio of the anti-inflammatory macrophages. The findings of this study underscore the pivotal role of platelet-membrane-coated and miR-181a-5p modified stem cell nanovesicles in facilitating postmyocardial infarction cardiac repair. By modulating macrophage polarization, P-181-NV offers a promising approach for enhancing the efficacy of targeted reparative interventions for damaged myocardium. These results contribute to our understanding of the potential of nanovesicles as therapeutic agents for cardiac repair and regeneration, presenting avenues for future research and clinical applications.
Authors
- Tianshuo Li (ORCID: https://orcid.org/0009-0004-4369-1523)
- Xianyun Wang (ORCID: https://orcid.org/0000-0003-2224-4770)
- Dongyue Liu (ORCID: https://orcid.org/0000-0001-7275-4985)
- Shasha Zeng
- Mingqi Zheng (ORCID: https://orcid.org/0000-0002-4300-0209)
- Mei Liu (ORCID: https://orcid.org/0000-0002-4960-0096)
- Le Wang (ORCID: https://orcid.org/0000-0002-6142-7134)
- Zhao Liu (ORCID: https://orcid.org/0009-0000-5103-9923)
- Fan Zhang (ORCID: https://orcid.org/0000-0003-1601-3036)
- Gang Liu (ORCID: https://orcid.org/0000-0003-1221-3698)
- Meng Li (ORCID: https://orcid.org/0000-0002-8348-6768)
- Jun Zhang (ORCID: https://orcid.org/0000-0002-5843-8705)
- Yida Tang (ORCID: https://orcid.org/0009-0003-4579-4449)
- Limin Ding
Institutions
- Hebei Medical University (CN)
- Peking University (CN)
- Hebei University of Chinese Medicine (CN)
- Peking University Third Hospital (CN)
- First Affiliated Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- ACS Applied Materials & Interfaces
- Published
- 2025-03-11
- DOI
- https://doi.org/10.1021/acsami.4c19325
- Citations
- 6
- Primary Topic
- Tissue Engineering and Regenerative Medicine
- Type
- article
- Field-Weighted Citation Impact
- 12.04
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Hebei Province
- Hebei Medical University
- Hebei Province Science and Technology Support Program